ArticlePlant biotechnology journal2026
Cell-Specific Expression and Cellular Compartmental Regulation in Camptothecin Biosynthesis.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Cell Insights into Medicinal Plant Development and Metabolism.Plants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Plant secondary metabolites such as monoterpenoid indole alkaloids (MIAs) show tightly regulated biosynthesis and accumulation in specific organelles of distinct cell types. However, the cell-specific expression patterns of anticancer MIA camptothecin biosynthetic genes in Ophiorrhiza pumila and the regulatory mechanisms of camptothecin biosynthesis via cellular compartmentalisation remain poorly understood. Here, single-cell RNA sequencing of O. pumila leaves generated 9181 cells, classified into four types using marker gene annotation and in situ hybridisation. Gene expression profiling combined with pseudotime analyses revealed that camptothecin biosynthetic genes are preferentially expressed in epidermal and young cells. Notably, the genes encoding camptothecin key enzymes, strictosidine synthase (STR) and tryptophan decarboxylase (TDC), have expanded within the O. pumila STR-TDC gene cluster, supporting cell-specific specialisation. Concurrently, this gene cluster has evolved a novel functional gene, OpAVT1, which annotated as a vacuolar transporter, mediates the transport of tryptophan from vacuole to the cytosol, thereby regulating camptothecin and other MIAs accumulation. Collectively, these findings establish a cellular-level framework for camptothecin biosynthesis and regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.